Zhejiang Ausun Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical formulatio...
CEC Capital advises Zhongkexinyang on 100-million-yuan private financing round
Ausun Pharm: Has repurchased a total of 5.2012 million shares, amounting to 50.006 million yuan
Ausun Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 207 million yuan, a year-on-year decrease of 9.59%
Ausun Pharm: Imatinib Mesylate Tablets Obtained Drug Registration Certificate
Ausun Pharm released its semi-annual performance report, with a net profit attributable to the parent company of 169 million yuan, a year-on-year decrease of 5.83%
Innovative drug concept stocks collectively declined, Ausun Pharm hit the limit down